By using an engineered strain of lactobacillus (human probiotics common in the gut of the body) that would secrete a Glucagen-like peptide (GPL-1), researchers saw that the engineered probiotic created up to a 30 percent lower high blood glucose in rats with diabetes. The team orally administered the engineered probiotics for 90 days to the rats.
Continue reading “Positive Treatment for Diabetic Rats with Engineered Probiotics”